{
    "organizations": [],
    "uuid": "70476536fb861d6b270f8ff980da64f494ecf5fa",
    "author": "",
    "url": "https://www.reuters.com/article/brief-strongbridge-biopharma-receives-no/brief-strongbridge-biopharma-receives-notice-of-allowance-from-u-s-patent-and-trademark-office-for-new-patent-covering-recorlev-idUSFWN1PD0OA",
    "ord_in_thread": 0,
    "title": "BRIEF-Strongbridge Biopharma Receives Notice Of Allowance From U.S. Patent And Trademark Office For New Patent Covering RECORLEV",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 18, 2018 / 12:40 PM / Updated 32 minutes ago BRIEF-Strongbridge Biopharma Receives Notice Of Allowance From U.S. Patent And Trademark Office For New Patent Covering RECORLEV Reuters Staff 1 Min Read \nJan 18 (Reuters) - Strongbridge Biopharma Plc: \n* STRONGBRIDGE BIOPHARMA RECEIVES NOTICE OF ALLOWANCE FROM U.S. PATENT AND TRADEMARK OFFICE FOR NEW PATENT COVERING RECORLEV™ (LEVOKETOCONAZOLE) FOR THE TREATMENT OF CUSHING’S SYNDROME \n* STRONGBRIDGE BIOPHARMA - ‍ TERM OF U.S. PATENT SCHEDULED TO ISSUE FROM APPLICATION WILL EXPIRE JAN 10, 2026, PLUS ANY TIME ALLOWED FOR TERM EXTENSION​ Source text for Eikon: Further company coverage:",
    "published": "2018-01-18T14:39:00.000+02:00",
    "crawled": "2018-01-18T15:17:01.048+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "updated",
        "minute",
        "ago",
        "biopharma",
        "receives",
        "notice",
        "allowance",
        "patent",
        "trademark",
        "office",
        "new",
        "patent",
        "covering",
        "recorlev",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "strongbridge",
        "biopharma",
        "plc",
        "strongbridge",
        "biopharma",
        "receives",
        "notice",
        "allowance",
        "patent",
        "trademark",
        "office",
        "new",
        "patent",
        "covering",
        "levoketoconazole",
        "treatment",
        "cushing",
        "syndrome",
        "strongbridge",
        "biopharma",
        "term",
        "patent",
        "scheduled",
        "issue",
        "application",
        "expire",
        "jan",
        "plus",
        "time",
        "allowed",
        "term",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}